Mineralys Therapeutics Ownership & Insider Activity

SPY777.28+0.01%QQQ758.44+0.09%BTC/USD83,113.29−2.85%DIA510.94−0.02%GLD376.08+0.05%TLT77.10−0.06%

Premium

Mineralys Therapeutics Inc

MLYSNASDAQ

Trade with Public

$22.09

0.140.64%

Last update: Oct 7, 4:37 PM

$22.38

0.431.96%

Overview News Earnings Forecast Events Price Targets Financials SentimentOwnershipCompare Options Stock Report

Mineralys Therapeutics Ownership & Insider Activity

Mineralys Therapeutics (MLYS) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 1.0% of shares outstanding. Institutional investors hold 44.9%. Over the past 90 days, insiders made 4 sales worth $5.7M.

Shares Outstanding

88.407M

Shares Float

73.847M

Insider Shares Owned

875.343K

Insider % Owned

1.0%

Institutional Shares Held

39.717M

Institutional % Held

44.9%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$5.7M total

Net Activity

Net Selling

Net Value (90d)

-$5.7M

Mineralys Therapeutics Insider Transactions (Last 6 Months)

See all insider trades →

Date	Insider	Title	Type	Shares	Price	Value
Sep 30, 2026	Jon Congleton	CHIEF EXECUTIVE OFFICER	SELL	75.000K	$25.46	$1.9M
Sep 22, 2026	Taylor Brian Slingsby	DIRECTOR	SELL	104.320K	$28.81	$3.0M
Sep 21, 2026	Eric Warren	CHIEF COMMERCIAL OFFICER	SELL-OPTIONS	—	$20.68	$111K
Sep 15, 2026	Daphne Karydas	DIRECTOR	SELL-OPTIONS	—	$20.30	$50K
Aug 21, 2026	Eric Warren	CHIEF COMMERCIAL OFFICER	SELL-OPTIONS	—	$19.61	$95K
Aug 10, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$21.55	$24K
Jul 21, 2026	Eric Warren	CHIEF COMMERCIAL OFFICER	SELL-OPTIONS	—	$20.06	$101K
Jul 17, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$20.98	$5K
Jul 13, 2026	Jon Congleton	CHIEF EXECUTIVE OFFICER	SELL	10.700K	$27.24	$291K
Jul 13, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL	6.349K	$17.28	$454K
Jul 9, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$23.15	$31K
Jun 30, 2026	Jon Congleton	CHIEF EXECUTIVE OFFICER	SELL	75.000K	$26.14	$2.0M
Jun 26, 2026	Eric Warren	CHIEF COMMERCIAL OFFICER	SELL-OPTIONS	—	$19.57	$1.3M
Jun 17, 2026	Daphne Karydas	DIRECTOR	SELL-OPTIONS	—	$18.51	$39K
Jun 15, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL	6.348K	$18.37	$248K
Jun 10, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$14.54	$165K
May 18, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$21.50	$5K
May 11, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL	6.349K	$18.68	$516K
Apr 17, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$23.38	$7K
Apr 13, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL	6.348K	$17.08	$446K
Apr 13, 2026	Jon Congleton	CHIEF EXECUTIVE OFFICER	SELL	15.730K	$26.83	$422K
Apr 9, 2026	Malcom David Rodman	CHIEF MEDICAL OFFICER	SELL-OPTIONS	—	$21.69	$25K

More with Benzinga EdgeGet Access

Mineralys Therapeutics Inc

Mineralys Therapeutics Ownership & Insider Activity

Mineralys Therapeutics Insider Transactions (Last 6 Months)

Mineralys Therapeutics Ownership & Insider Activity

Mineralys Therapeutics Insider Transactions (Last 6 Months)

People Also Watch

People Also Watch